指南与共识类风湿关节炎系统性红斑狼疮其他结缔组织病

美国风湿病学会新冠疫情期间成人风湿病管理指南(第二版)

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2.
指南 / 共识 · Arthritis Rheumatol · 2020-07-30

该指南由北美10名风湿病学家和4名感染病专家组成的工作组制定,采用改良Delphi流程匿名投票,最终形成27条指南声明,用于指导新冠疫情期间成人风湿病的管理,并计划作为「活文件」持续更新。

要点

  • 工作组由10名风湿病学家和4名感染病专家组成,采用改良Delphi流程达成共识。
  • 共批准80条指导声明(36条中度共识、44条高度共识),合并为27条最终指南声明。
  • 因证据水平低且文献快速演变,指南作为「活文件」发布,预计未来更新。

核心结论

  • 这些指南声明旨在新冠疫情期间促进最佳的风湿病诊疗,但因证据有限而作为「活文件」持续更新。

研究设计与样本

  • 工作组由来自北美的10名风湿病学家和4名感染病专家组成,快速生成证据报告,采用改良Delphi流程(异步匿名邮件投票和网络研讨会)对声明进行评审和投票。

主要发现

  • 工作组已批准80条指导声明,其中36条为中度共识、44条为高度共识,合并后形成27条最终指南声明。

关键数值与推荐

  • 投票采用1-9分数字评分系统,中位数7-9定义为同意、4-6为不确定、1-3为不同意,结合共识水平(低、中、高)批准声明。
  • 最终批准27条指南声明,包括36条中度共识和44条高度共识的指导声明。

临床怎么用

  • 风湿病诊疗提供者在新冠疫情期间可参考这27条最终指南声明进行成人风湿病管理。

局限性

  • 现有证据水平低且文献快速演变,指南作为「活文件」发布,未来预计更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID-19) pandemic. METHODS: A task force, including 10 rheumatologists and 4 infectious disease specialists from North America, was convened. Clinical questions were collated, and an evidence report was rapidly generated and disseminated. Questions and drafted statements were reviewed and assessed using a modified Delphi process. This included asynchronous anonymous voting by e-mail and webinars with the entire panel. Task force members voted on agreement with draft statements using a 1-9-point numerical scoring system, and consensus was determined to be low, moderate, or high based on the dispersion of votes. For approval, median votes were required to meet predefined levels of agreement (median values of 7-9, 4-6, and 1-3 defined as agreement, uncertainty, or disagreement, respectively) with either moderate or high levels of consensus. RESULTS: To date, the task force has approved 80 guidance statements: 36 with moderate and 44 with high consensus. These were combined, resulting in 27 final guidance statements. CONCLUSION: These guidance statements are provided to promote optimal care during the current pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a "living document," and future updates are anticipated.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2. Arthritis Rheumatol. 2020. PMID: 32734689. doi:10.1002/art.41437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。